- Filed
- Feb 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 28, 2025 | 8.08M sh |
| Shares Diluted | FY 2024 · Nov 30, 2023 | 8.34M sh |
| Stock Repurchased | FY 2024 · Nov 30, 2023 | $799.04K |
| Dividends Paid | FY 2024 · Nov 30, 2023 | $0 |
| Capex | FY 2024 · Nov 30, 2023 | $6.84M |
| Operating Cash Flow | FY 2024 · Nov 30, 2023 | $8.92M |
| Cash And Equivalents | FY 2024 · Nov 30, 2023 | $406.07K |
| Current Liabilities | FY 2024 · Nov 30, 2023 | $20.86M |
| Total Liabilities | FY 2024 · Nov 30, 2023 | $72.25M |
| Current Assets | FY 2024 · Nov 30, 2023 | $9.45M |
| Total Assets | FY 2024 · Nov 30, 2023 | $61.22M |
| Eps Diluted | FY 2024 · Nov 30, 2023 | −$1.14 |
| Eps Basic | FY 2024 · Nov 30, 2023 | −$1.14 |
| Sga Expense restated | FY 2024 · Nov 30, 2023 | $17.17M |
| Rd Expense | FY 2024 · Nov 30, 2023 | $1.17M |
| Net Income | FY 2024 · Nov 30, 2023 | −$9.52M |
| Operating Income | FY 2024 · Nov 30, 2023 | −$12.3M |
| Cost Of Revenue restated | FY 2024 · Nov 30, 2023 | $8.39M |
| Stockholders Equity | FY 2024 · Nov 30, 2022 | −$1.52M |